ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2308건의 자료가 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2217 | Unknown status | A Proof-of-Concept Study Evaluating EOM613 in COVID-19 Infected Patients With Severe Symptoms | COVID-19 Acute Respiratory Distress Syndrome | Drug: EOM613 | Phase 1 | EOM Pharmaceuticals | INDUSTRY | 40 | All | 18 Years ~ 84 Years | Oswaldo Cruz, Manguinhos, Rio De Janeiro, Brazil Hospital de Amor, Barretos, Sao Paulo, Brazil Hospital Municipal de Barueri, Barueri, Sao Paulo, Brazil Casa De Saude, Boqueirao, Sao Paulo, Brazil |
| 2216 | Terminated | A Prospective, Phase II Study to Evaluate Safety of 101-PGC-005 ('005) for Moderate to Severe COVID-19 Disease Along With Standard of Care | COVID-19 | Drug: 101-PGC-005 ('005) + SOC Drug: Placebo + SOC |
Phase 2 | 101 Therapeutics | INDUSTRY | 3 | All | 18 Years | The COVID-19 Unit, Rambam Health Care Campus, Haifa, Israel |
| 2215 | Recruiting | A Randomised, Multi-centre, Double-blind, Phase 3 Study to Observe the Effectiveness, Safety and Tolerability of Molnupiravir Compared to Placebo Administered Orally to High-risk Adult Outpatients With Mild COVID-19 Receiving Local Standard of Care in South Africa | COVID-19 | Drug: Molnupiravir 200 mg | Phase 3 | University of Witwatersrand, South Africa, Bill and Melinda Gates Foundation | OTHER | 4000 | All | 50 Years | Nelson Mandela Academic Clinical Research Unit (NeMACRU), Umtata, Eastern Cape, South Africa Sunnyside Office Park, Johannesburg, Gauteng, South Africa Nelson R. Mandela School of Medicine 3rd Floor, K-RITH Tower Building, Durban, Kwa-Zulu Natal, South Africa The Aurum Institute: Gavin J Churchyard Legacy Centre Klerksdorp Clinical Research Centre, Klerksdorp, North West, South Africa |
| 2214 | Terminated | A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients | COVID-19 | Drug: Hydroxychloroquine | Phase 3 | Queen's Medical Center | OTHER | 17 | All | 18 Years ~ 95 Years | Queen's Medical Center, Honolulu, Hawaii, United States |
| 2213 | Withdrawn | A Randomized Controlled Trial Assessing the Efficacy of Lianhua Qingwen as an Adjuvant Treatment in Patients With Mild Symptoms of COVID-19 | COVID-19 | Drug: Lianhua Qingwen Drug: Placebo |
Phase 3 | Nanyang Technological University, Ministry of Health, Singapore | OTHER | 0 | All | 21 Years | |
| 2212 | Unknown status | A Randomized Controlled Trial to Investigate The Role of Adjuvant Inhalable Sodium Bicarbonate Solution 8.4% in Treatment of COVID-19 | COVID-19 Acute Respiratory Distress Syndrome | Drug: Sodium Bicarbonate Solution Drug: Placebo |
Not Applicable | Mansoura University | OTHER | 340 | All | 18 Years | Mansoura University Hospital - Chest Departement, Mansoura, DK, Egypt |
| 2211 | Completed | A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection | COVID-19 | Drug: Clazakizumab 25 mg Drug: Clazakizumab 12.5 mg Other: Placebo |
Phase 2 | NYU Langone Health | OTHER | 178 | All | 18 Years | Mayo Clinic, Phoenix, Arizona, United States The Johns Hopkins Hospital, Baltimore, Maryland, United States New York University School of Medicine, New York, New York, United States |
